Natural Secretory Products of Human Neural and Microvessel Endothelial Cells: Implications in Pathogenic "Spreading" and Alzheimer's Disease
- 1 January 2006
- journal article
- review article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 34 (3) , 181-192
- https://doi.org/10.1385/mn:34:3:181
Abstract
Neurons, glia, and endothelial cells of the cerebral microvasculature co-exist in intimate proximity in nervous tissues, and their homeostatic interactions in health, as well as coordinated response to injury, have led to the concept that they form the basic elements of a functional neurovascular unit. During the course of normal cellular metabolism, growth, and development, each of these brain cell types secrete various species of potentially neurotoxic peptides and factors, events that increase in magnitude as brain cells age. This article reviews contemporary research on the secretory products of the three primary cell types that constitute the neurovascular unit in deep brain regions. We provide some novel in vitro data that illustrate potentially pathogenic paracrine effects within primary cells of the neurovascular unit. For example, the pro-inflammatory cytokine interleukin (IL)-1β was found to stimulate amyloid-β (Aβ) peptide release from human neural cells, and human brain microvessel endothelial cells exposed to transient hypoxia were found to secrete IL-1β at concentrations known to induce Aβ42 peptide release from human neural cells. Hypoxia and excessive IL-1β and Aβ42 abundance are typical pathogenic stress factors implicated in the initiation and development of common, chronic neurological disorders such as Alzheimer's disease. These data support the hypothesis that paracrine effects of stressed constituent cells of the neurovascular unit may contribute to “spreading effects” characteristic of progressive neurodegenerative disorders.Keywords
This publication has 70 references indexed in Scilit:
- Role of astrocytes in cerebrovascular regulationJournal of Applied Physiology, 2006
- Sequence Determinants of Enhanced Amyloidogenicity of Alzheimer Aβ42 Peptide Relative to Aβ40Journal of Biological Chemistry, 2005
- Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's diseaseThe FASEB Journal, 2005
- Alzheimer’s Disease—A Dysfunction in Cholesterol and Lipid MetabolismCellular and Molecular Neurobiology, 2005
- Clearance of Alzheimer's Aβ PeptideNeuron, 2004
- Pathways towards and away from Alzheimer's diseaseNature, 2004
- Secretion and Intracellular Generation of Truncated Aβ in β-Site Amyloid-β Precursor Protein-cleaving Enzyme Expressing Human NeuronsPublished by Elsevier ,2003
- Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculationNature Neuroscience, 2002
- Alzheimer Disease as a Vascular DisorderStroke, 2002
- The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formationNature Neuroscience, 2001